The preservative-free corticosteroid is approved by the FDA for vitrectomy visualization, as well as the treatment of recalcitrant ocular inflammation.
PentaVision is an independent company dedicated to eye care professionals. More about our magazines, newsletters, conferences, education and other services at pentavisionmedia.com.
Biomea Fusion announced a clinical hold by the U.S. FDA on its diabetes drug trial due to potential toxic liver disease, causing a 60% drop in its shares.